Evaluation of Right To Play's Positive Child and Youth Development Program in Middle Schools in Hyderabad, Pakistan
NCT ID: NCT03448523
Last Updated: 2018-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1752 participants
INTERVENTIONAL
2015-12-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Play and Care Together (PACT) Implementation
NCT05590975
Effectiveness of the WHO Caregivers Skills Training Program
NCT04255472
Early Adolescent Skills for Emotions (EASE)-Pilot Cluster Randomized Controlled Trial (cRCT) in Public Schools of Rural Pakistan
NCT04254393
Learning Through Play (LTP) Plus Interpersonal Psychotherapy (IPT)
NCT03430622
Family Networks (FaNs) for Children With Developmental Disorders and Delays
NCT02792894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A two-arm, cluster randomised controlled trial based in middle schools in Hyderabad, Sindh province, Pakistan is evaluating this intervention. It is being conducted in 40 schools, half are boys schools (20) and half (20) girls'. Twenty of the schools have been randomised to the intervention arm and twenty to the control (delayed intervention) arm. The outcomes will be addressed using quantitative methods with data collected from students in Grade 6 at the start of the trial. These measures will be conducted pre-intervention and 12, and 24 month follow up periods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Right To Play's Positive Child and Youth Development program
Behavioural intervention
Right To Play's Positive Child and Youth Development program
1. Right To Play's Red Ball Child Play manual provided for 60 hours per annum for two years
2. Training of junior leaders
3. Related play-based activities such as sports days
4. Quarterly awareness sessions with community groups and parents
5. Summer camps for children
6. training of teachers on Right To Play's foundational resources, positive disciplining, and gender and child protection
Control
No intervention; intervention to be offered after end line assessment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Right To Play's Positive Child and Youth Development program
1. Right To Play's Red Ball Child Play manual provided for 60 hours per annum for two years
2. Training of junior leaders
3. Related play-based activities such as sports days
4. Quarterly awareness sessions with community groups and parents
5. Summer camps for children
6. training of teachers on Right To Play's foundational resources, positive disciplining, and gender and child protection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
School student participants: enrolled in grade 6 in one of the study schools; informed consent from parent and child; able to read the national language Urdu or provincial language Sindhi
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aga Khan University
OTHER
Texas Woman's University
OTHER
Medical Research Council, South Africa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC025-8/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.